Advertisement

Picture Berlin Partner Hotspot for Startups 650x80px
Document › Details

Kiadis Pharma N.V.. (5/30/19). "Press Release: Kiadis Pharma Launches a Private Placement of New Shares to Raise approximately EUR 25 Million [Not for US, AU, CA, JP, ZA, et al.]". Amsterdam.

Organisations Organisation Kiadis Pharma N.V. (Euronext: KDS)
  Group Kiadis (Group)
  Organisation 2 Piper Jaffray & Co. (NYSE: PJC)
  Today Piper Sandler Companies (NYSE: PIPR)
  Group Piper Sandler (Group)
Products Product ATIR101™ (Kiadis)
  Product 2 investment banking
Index terms Index term Kiadis–SEVERAL: investment, 201905 private placment €27.6m with 3.68m new shares at €7.5/share
  Index term 2 CytoSen Therapeutics–Kiadis: investment, 201904– acquisition merger in shares with 1.94m shares (7.4%) upfront plus 5.82 shares milestones
Persons Person Sullivan, Amy (Kiadis 201901– SVP Corporate Affairs before Keryx Biopharmaceuticals + AMAG Pharmaceuticals + Idenix)
  Person 2 Clark, Mary (Optimum Strategic Communications 201710 before Hume Brophy + M:Communications + Capital MSL)
     


   
Record changed: 2019-06-06

Advertisement

Picture EBD Group Connector Personal Networking in Life Sciences 650x80

More documents for Kiadis (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture Berlin Partner Network in German Capital Region 650x80px




» top